Harrow Announces Participation in Upcoming Investor Conferences

NASHVILLE, Tenn.--(BUSINESS WIRE)--Nov. 15, 2024-- Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, today announced that management will participate in the following three investor conferences:

Craig-Hallum 15^th Annual Alpha Select Conference (Sheraton New York Times Square Hotel)
November 19, 2024
1x1 Meetings Only

BTIG 4^th Annual Ophthalmology Day (Virtual)
December 2, 2024
1x1 Virtual Meetings Only

Piper Sandler 36^th Annual Healthcare Conference (The Lotte New York Palace)
December 3-5, 2024
Company will host a Fireside Chat at 8:00 a.m. ET on December 4, 2024

The Company will conduct one-on-one meetings at each conference. Investors interested in meeting with management during conferences should contact their representative at each firm to request a meeting. Only the Piper Sandler conference will include an audio webcast, which will be available on the Company's website.

About Harrow
Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market. Harrow helps eyecare professionals preserve the gift of sight by making its portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of patients each year. For more information about Harrow, please visit harrow.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241115031085/en/

Jamie Webb, Director of Communications and Investor Relations
[email protected]
615-733-4737

Source: Harrow, Inc.